These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 565414)

  • 1. Effect of adriamycin on the reproductive integrity of cultured leukemia L1210 and P388 cells.
    Wilkott LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1978 May; 60(5):1117-20. PubMed ID: 565414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of adriamycin-14-octanoate over adriamycin in reducing viability of methotrexate-resistant L5178Y cells: brief communication.
    Hill BT; Price LA
    J Natl Cancer Inst; 1977 Oct; 59(4):1311-4. PubMed ID: 561857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.
    Wilkoff LJ; Dulmadge EA
    J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of chlorambucil activity by phenylbutazone.
    Schiffman FJ; Uehara Y; Fisher JM; Rabinovitz M
    Cancer Lett; 1978 Apr; 4(4):211-6. PubMed ID: 647661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F; Vietti T; Coulter D
    J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
    Priebe W; Neamati N; Perez-Soler R
    J Antibiot (Tokyo); 1990 Jul; 43(7):838-46. PubMed ID: 2387778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
    Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
    Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
    Israel M; Modest EJ; Frei E
    Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
    Pratesi G; Casazza AM; Di Marco A
    Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
    Sladek NE; Landkamer GJ
    Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of adriamycin in overcoming resistance to methotrexate in tissue culture.
    Hill BT; Price LA; Goldies JH
    Eur J Cancer (1965); 1976 Jul; 12(7):541-9. PubMed ID: 986302
    [No Abstract]   [Full Text] [Related]  

  • 14. N-salicylidene derivatives of pirarubicin.
    Ajito K; Ikeda D; Komuro K; Nosaka C; Wako N; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1133-44. PubMed ID: 2753818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of reduction in viability of cultured leukemia L1210 cells exposed to purine analogs.
    Wilkoff LJ; Dulmadge EA; Lloyd HH
    Chemotherapy; 1977; 23(3):179-91. PubMed ID: 402255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chartreusin on cell survival and cell cycle progression.
    Bhuyan BK; Robinson MI; Shugars KD; Bono VH; Dion RL
    Cancer Res; 1978 Sep; 38(9):2734-9. PubMed ID: 567096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
    Ganapathi R; Yen A; Grabowski D; Schmidt H; Turinic R; Valenzuela R
    Br J Cancer; 1986 Apr; 53(4):561-6. PubMed ID: 3707847
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R; Grabowski D
    Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium influx blocker verapamil on adriamycin-induced cytotoxicity in leukemia cells in vitro.
    Mircheva JJ; Tsuruo T
    Acta Physiol Pharmacol Bulg; 1989; 15(4):3-8. PubMed ID: 2634901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.